Process for the production of Vitamin A

A novel two-step synthetic process for vitamin A and its derivatives addresses the complexity of existing methods, achieving efficient and high-yield production.

JP2024541827AInactive Publication Date: 2024-11-13DSM IP ASSETS BV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024521312
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-11-26
Filing Date
2022-11-23
Publication Date
2024-11-13
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing manufacturing processes for vitamin A and its derivatives are complex and in need of improvement.

Method used

A novel two-step synthetic process involving the reaction of compounds of formula (III) with formula (IV) in the presence of a strong base and at controlled temperatures, using specific solvents and molar ratios, to produce vitamin A or its derivatives.

Benefits of technology

The process efficiently synthesizes vitamin A and its derivatives with high yield and purity, allowing for improved manufacturing efficiency and quality.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024541827000001
    Figure 2024541827000001
  • Figure 2024541827000002
    Figure 2024541827000002
  • Figure 2024541827000003
    Figure 2024541827000003
Patent Text Reader

Abstract

The present invention relates to a novel process for the production of vitamin A and / or its derivatives.
Need to check novelty before this filing date? Find Prior Art

Description

Detailed Description of the Invention

[0001] The present invention relates to a novel process for the production of vitamin A and / or its derivatives.

[0002] Vitamin A or its derivatives (such as vitamin A acetate, vitamin A propionate, or vitamin A palmitate) [ka] Vitamin A is an important component for many applications. It plays a role in many functions throughout the body, including visual processes, gene transcription, immune function, bone metabolism, blood formation, skin and cellular health, and antioxidant function.

[0003] Due to the importance of vitamin A (and its derivatives) and the complexity of its synthesis, there is a constant need for improved manufacturing processes.

[0004] The object of the present invention was to find a new synthesis of vitamin A or its derivatives. This object was achieved by the synthetic route of the present invention.

[0005] The novel synthesis for obtaining vitamin A and / or its derivatives can be seen from the following scheme: The following scheme illustrates how vitamin A (or a derivative thereof) can be obtained, which is a compound of formula (I): [ka] (wherein R is H, or [ka] R1 is a linear or branched C1-C 18 (the alkyl moiety).

[0006] In the context of this patent application, the carbon-carbon double bonds of the compounds shown in the patent application can have any EZ configuration. The EZ configuration is not an essential feature of the invention.

[0007] The novel process consists of two steps: step (i) and step (ii).

[0008] The compounds of formula (II) can be prepared according to any process known from the prior art.

[0009] Another starting material which is a compound of formula (III) is a compound of formula (VI) [ka] wherein R and R1 have the same meanings as defined for the compound of formula (III) with SO2 in an inert solvent.

[0010] Methods for obtaining compounds of formula (VI) are known from the prior art (eg from Z. Wu et al, J. Am. Chem. Soc., 2005, 17433).

[0011] Thus, the present invention relates to a compound of formula (I) [ka] (wherein R is H, or [ka] R1 is a linear or branched C1-C 18 a process (P) for the production of a compound of formula (I) In the first step (step (i)), a compound represented by the formula (II) [ka] The compound of formula (III) [ka] where R (and also R1) have the same meaning as defined for the compounds of formula (I), Then, in the second step (step (ii)), a compound of formula (IV) [ka] wherein R (and also R1) have the same meaning as defined for the compound of formula (I), is converted into the compound of formula (I) by heating the reaction mixture.

[0012] Preferably, in the compound of formula (I) R is H, or [ka] wherein R1 is -CH3, -CH2CH3 or -(CH2) 14 It is CH3.

[0013] More preferably, R is [ka] It is.

[0014] Most preferably, R is [ka] It is.

[0015] Thus, the present invention relates to a process (P1), which is a process (P), wherein R is H or [ka] wherein R1 is -CH3, -CH2CH3 or -(CH2) 14 It is CH3.

[0016] Thus, the present invention relates to a process (P1′), which is a process (P), in which R is [ka] It is.

[0017] Thus, the present invention relates to a process (P1″), which is a process (P), in which R is [ka] It is.

[0018] The two steps are described in more detail below.

[0019] [Process (i)] In the first step according to the invention, 2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-2-enal (also known as boronal), a compound of formula (II), is prepared by reacting a compound of formula (III), [ka] R1 is a linear or branched C1-C 18 is an alkyl moiety) to form a compound of formula (IV) (wherein R1 has the same meaning as defined for compounds of formula (III): [ka]

[0020] The process of step (i) is usually carried out in at least one inert solvent.

[0021] The solvent is usually a polar aprotic solvent or a non-polar aprotic solvent. Suitable solvents are, for example, THF, diethyl ether, cyclopentyl methyl ether, tert-butyl methyl ether, MeTHF, toluene, heptane and n-hexane.

[0022] Thus, the present invention relates to a process (P2), which is a process (P), (P1'), (P1') or (P1''), wherein the reaction of step (i) is carried out in at least one inert solvent.

[0023] Thus, the present invention relates to a process (P2'), which is process (P2), wherein the at least one inert solvent is a polar aprotic solvent or a non-polar aprotic solvent.

[0024] Thus, the present invention relates to a process (P2″), which is a process (P2), wherein the at least one inert solvent is selected from the group consisting of THF, diethyl ether, cyclopentyl methyl ether, tert-butyl methyl ether, MeTHF, toluene, heptane and n-hexane.

[0025] Furthermore, the reaction of step (i) is carried out in the presence of at least one strong base. B The value is less than 2.

[0026] Suitable bases are, for example, NaH, n-BuLi, tert-BuLi, sec-BuLi, LiHMDS, NaHMDS, LDA, NaDA, NaNH2, KNH2, LiNH2, organic amine bases, NaNH2, LiNH2, and the analogous potassium salts of these bases.

[0027] The strong base in step (i) is usually used in an amount of 0.8 to 2.5 molar equivalents relative to the compound of formula (III).

[0028] Thus, the present invention relates to process (P3), which is process (P), (P1'), (P1'), (P1''), (P2), (P2') or (P2''), wherein the reaction of step (i) is carried out in the presence of at least one strong base.

[0029] Thus, the present invention relates to a process (P3'), which is a process (P3), in which the pK B The value is less than 2.

[0030] Thus, the present invention relates to a process (P3″), which is process (P2), wherein the at least one strong base is selected from the group consisting of NaH, n-BuLi, tert-BuLi, sec-BuLi, LiHMDS, NaHMDS, LDA, NaDA, NNaNH2, KNH2, LiNH2, organic amine bases, NaNH2, LiNH2 and the analogous potassium salts of these bases.

[0031] Thus, the present invention relates to a process (P3'''), which is a process (P3), (P3') or (P3''), wherein the at least one strong base is used in an amount of 0.8 to 2.5 molar equivalents relative to the compound of formula (III).

[0032] Furthermore, the reaction of step (i) is carried out at low temperature.

[0033] Preferably, the reaction in step (i) is carried out at a temperature of from -90°C to 25°C.

[0034] More preferably, the reaction in step (i) is carried out at a temperature of -80°C to 5°C.

[0035] Thus, the present invention relates to process (P4), which is process (P), (P1'), (P1'), (P1"), (P2), (P2'), (P2"), (P3), (P3'), (P3") or (P3'"), wherein the reaction of step (i) is carried out at low temperature.

[0036] Accordingly, the present invention relates to a process (P4'), which is process (P4), wherein the reaction of step (i) is carried out at a temperature between -90°C and 25°C.

[0037] Thus, the present invention relates to a process (P4''), which is a process (P4), wherein the reaction of step (i) is carried out at a temperature between -80°C and 5°C.

[0038] Furthermore, the compound of formula (II) and the compound of formula (III) are usually used in a molar ratio of 0.8:1 to 1:0.8 in the reaction of step (i).

[0039] Thus, the present invention relates to process (P5), which is process (P), (P1'), (P1'), (P1''), (P2), (P2'), (P2''), (P3), (P3'), (P3''), (P3'''), (P4), (P4') or (P4''), wherein the compound of formula (II) and the compound of formula (III) are used in a molar ratio of 0.8:1 to 1:0.8 in the reaction of step (i).

[0040] At the end of the reaction of step (i), which usually takes place over a period of a few minutes to a few hours, the reaction product of formula (IV) can be isolated (and optionally purified) and then used in step (ii).

[0041] However, it is also possible to use the reaction mixture of step (i) as it is in step (ii).

[0042] [Step (ii)] In the second step according to the invention, a compound of formula (IV) [ka] The compound of formula (III) is dissolved in at least one inert solvent, wherein R (and also R1) has the same meaning as defined for the compound of formula (III).

[0043] Typically and preferably, the inert solvent is a polar aprotic solvent or a non-polar aprotic solvent.

[0044] If the reaction mixture of step (i) is used as is in step (ii), it is not necessary to add a solvent (although it is possible to add a solvent in this case).

[0045] Suitable solvents are, for example, THF, diethyl ether, cyclopentyl methyl ether, tert-butyl methyl ether, MeTHF, toluene, heptane and n-hexane.

[0046] Thus, the present invention relates to process (P6), which is process (P), (P1'), (P1'), (P1'', (P2), (P2'), (P2'', (P3), (P3'), (P3'', (P3''',), (P4), (P4'), (P4'') or (P5), in which in step (ii), a compound of formula (IV) [ka] The reaction product of step (i), which is a compound of the formula: (wherein R (and also R1) have the same meaning as defined for the compound of formula (III), is dissolved in at least one inert solvent.

[0047] Thus, the present invention relates to a process (P6'), which is process (P6), wherein the at least one inert solvent is a polar aprotic solvent or a non-polar aprotic solvent.

[0048] Thus, the present invention relates to a process (P6″), which is process (P6) or (P5′), wherein the at least one inert solvent is selected from the group consisting of THF, diethyl ether, cyclopentyl methyl ether, tert-butyl methyl ether, MeTHF, toluene, heptane and n-hexane.

[0049] The reaction of step (ii) is carried out at an elevated temperature.

[0050] Typically and preferably, the reaction in step (ii) is carried out at a temperature of from 40°C to 120°C.

[0051] Thus, the present invention relates to process (P7), which is process (P), (P1'), (P1'), (P1"), (P2), (P2'), (P2"), (P3), (P3'), (P3"), (P3"'), (P4), (P4'), (P4"), (P5), (P6), (P6') or (P6"), wherein the reaction of step (ii) is carried out at elevated temperature.

[0052] Accordingly, the present invention relates to a process (P7'), which is process (P7), wherein the reaction of step (ii) is carried out at a temperature between 40°C and 120°C.

[0053] Step (ii) may be carried out in the presence or absence of at least one nitrogenous base.

[0054] Thus, the present invention relates to process (P8), which is process (P), (P1'), (P1'), (P1"), (P2), (P2'), (P2"), (P3), (P3'), (P3"), (P3"'), (P4), (P4'), (P4"), (P5), (P6), (P6'), (P6"), (P7) or (P7'), wherein the reaction of step (ii) is carried out in the presence of a nitrogenous base.

[0055] Thus, the present invention relates to process (P9), which is process (P), (P1'), (P1'), (P1"), (P2), (P2'), (P2"), (P3), (P3'), (P3"), (P3"'), (P4), (P4'), (P4"), (P5), (P6), (P6'), (P6"), (P7) or (P7'), wherein the reaction of step (ii) is carried out in the absence of a nitrogenous base.

[0056] The reaction of step (ii) is usually carried out for several hours.

[0057] At the end of the reaction of step (ii), the reaction product of step (ii), which is the compound of formula (I), can be isolated and purified by commonly known and used methods.

[0058] However, it is also possible to use the reaction mixture of step (ii) as is.

[0059] A further embodiment of the present invention is a compound of formula (IV) [ka] (wherein R is H, or [ka] R1 is a linear or branched C1-C 18 The present invention relates to novel compounds in which the substituents are alkyl groups.

[0060] Thus, the present invention relates to a compound represented by formula (IV) [ka] (wherein R is H, or [ka] R1 is a linear or branched C1-C 18 The present invention relates to compounds in which the alkyl moiety is an alkyl group.

[0061] Preferred are compounds of the following formulae (IVa), (IVb), (IVc) and (IVd): [ka] It is a compound of the formula:

[0062] Thus, the present invention relates to compounds of formula (IVa), (IVb), (IVc) and (IVd) [ka] The present invention relates to a compound of the formula:

[0063] Additionally, the process of step (ii) may be followed by analytical methods (eg, NMR) to confirm the progress of the reaction.

[0064] In step (ii), it was found that two intermediates could be detected: [ka]

[0065] Thus, the present invention relates to a compound of formula (Vb) [ka] (wherein R is H, or [ka] R1 is a linear or branched C1-C 18 The present invention relates to compounds in which the alkyl moiety is an alkyl group.

[0066] Thus, the present invention provides compounds of formula (V'b), (V''b), (V'''b) and (V''''b) [ka] The present invention relates to a compound of the formula:

[0067] The following examples serve to illustrate the invention. Temperatures are given in ° C. and all percentages relate to weight.

[0068] [Example] Example 1: Retinyl acetate by compound of formula (IVa) In a two-necked round-bottom flask, 14The aldehyde ((II), (E)-2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl))but-2-enal) (260 mg) and (3-methyl-1,1-dioxido-2,5-dihydrothiophen-2-yl)methyl acetate (268 mg) were dissolved in anhydrous THF (3.75 ml). Under an inert gas atmosphere, the reaction mixture was cooled to -75°C. A 2M solution of LDA in THF / n-hexane (1.25 ml, 2.08 equiv.) was added dropwise and stirring was continued at -75°C for another 10 min. The cooling bath was removed and a half-saturated NH4Cl solution (12.5 ml) was added. The biphasic mixture was transferred to a separatory funnel and extracted with diethyl ether (2 x 25 ml). The combined organic extracts were subsequently washed with water (2×12.5 ml) and brine (12.5 ml), filtered and concentrated under reduced pressure (40° C., 5 mbar). The crude product (521 mg) was obtained as a yellow oil. After purification by column chromatography (SiO, cyclohexane / ethyl acetate 8:2), 163.3 mg of formula (IVa) was obtained. [ka] The compound was obtained.

[0069] The oil was placed in a dry, two-necked round-bottom flask and dissolved in toluene (5 mL) under an argon atmosphere. The reaction mixture was heated to reflux for 4 h. All volatiles were evaporated under reduced pressure (40° C., 5 mbar) to give retinyl acetate.

[0070] [Example 2: Compound of formula (IVb)] In a two-neck round-bottom flask, 14The aldehyde ((II), (E)-2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-2-enal) (260 mg) and (3-methyl-1,1-dioxido-2,5-dihydrothiophen-2-yl)methylpropionate (281 mg) were dissolved in anhydrous THF (3.75 ml). The mixture was cooled to -75°C under inert conditions with an acetone / dry ice cooling bath. A 2M solution of LDA in THF / n-hexane (1.25 ml, 2.08 equiv.) was added dropwise and stirring was continued at -75°C for a further 10 min. The cooling bath was removed and a half-saturated NH4Cl solution (12.5 ml) was added. The biphasic mixture was transferred to a separatory funnel and extracted with diethyl ether (2 x 25 ml). The combined organic extracts were subsequently washed with water (2×12.5 ml) and brine (12.5 ml), filtered and concentrated under reduced pressure (40° C., 5 mbar). The crude product was obtained as a yellow oil. After purification by column chromatography (SiO2, cyclohexane / ethyl acetate 8:2), 115 mg of the compound of formula (IVb) was obtained. [ka] The compound was obtained.

Claims

1. Formula (I) [Formula 1] (wherein R is H, or [Case 2] and R 1 is a linear or branched C 1 ~C 18 wherein the alkyl moiety is an alkyl moiety, In the first step (step (i)), a compound of formula (II) [C3] The compound of formula (III) [C4] (Wherein, R (and R 1 (also) reacts with a compound of formula (I) having the same meaning as defined above for the compound of formula (I), Then, in the second step (step (ii)), a compound represented by the formula (IV) [C5] (Wherein, R (and R 1 wherein R 1 has the same meaning as defined for said compound of formula (I), is converted into said compound of formula (I) by heating the reaction mixture.

2. 2. The process of claim 1, wherein the reaction of step (i) is carried out in at least one inert solvent.

3. 3. The process of claim 2, wherein the at least one inert solvent is a polar aprotic solvent or a non-polar aprotic solvent.

4. 4. The process of claim 2 or 3, wherein the at least one inert solvent is selected from the group consisting of cyclopentyl methyl ether, tert-butyl methyl ether, MeTHF, toluene, heptane and n-hexane.

5. The process according to any one of claims 1 to 4, wherein the reaction of step (i) is carried out in the presence of at least one strong base.

6. pK of a strong base (or mixture of bases) B The process of claim 5 , wherein the value is less than 2.

7. The process according to claim 5 or 6, wherein the at least one strong base is used in an amount of 0.8 to 2.5 molar equivalents relative to the compound of formula (III).

8. The process of any one of claims 1 to 7, wherein the reaction of step (i) is carried out at a temperature of from -90°C to 25°C.

9. Step (ii), formula (IV) [C6] 9. The process according to any one of claims 1 to 8, wherein the reaction product of step (i), the compound of formula (I), wherein R has the same meaning as defined for the compound of formula (I), is dissolved in at least one inert solvent.

10. 10. The process of claim 9, wherein the at least one inert solvent is a polar aprotic solvent or a non-polar aprotic solvent.

11. 11. The process of claim 9 or 10, wherein the at least one inert solvent is selected from the group consisting of THF, diethyl ether, cyclopentyl methyl ether, tert-butyl methyl ether, MeTHF, toluene, heptane and n-hexane.

12. The process of any one of claims 1 to 11, wherein the reaction in step (ii) is carried out at elevated temperature.

13. 13. The process of claim 12, wherein the reaction of step (ii) is carried out at a temperature of from 40° C. to 120° C.

14. Formula (IV) [C7] (wherein R is H, or [C8] and R 1 is a linear or branched C 1 ~C 18 The compound is an alkyl moiety.

15. Formula (Vb) [C9] (wherein R is H, or [C10] and R 1 is a linear or branched C 1 ~C 18 The compound is an alkyl moiety.